Market Overview

THRX Initiated With Overweight At Piper Jaffray

Analysts at Piper Jaffray initiate coverage of Theravance (NASDAQ: THRX) with an "overweight" rating. The target price for THRX is set to $16.

TRRX gained 1.81% to close at $12.97 on Friday. More Analyst Ratings here

Posted-In: Piper JaffrayEarnings Long Ideas Initiation Markets Analyst Ratings Trading Ideas

 

Related Articles (THRX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters